On the other hand, NFIB acts as a tumor suppressor in other cancers including osteosarcoma 20, cutaneous squamous cell carcinoma 21, and non–small‐cell lung cancer (NSCLC) 22. Here, NFIB is linked to non-small cell lung carcinoma.